Introduction
============

Tumor necrosis factor (TNF)-α is a multifunctional cytokine involved in important biological processes, including cell survival, proliferation, differentiation and death [@B1]. It also plays a crucial role in the pathogenesis of a variety of human diseases. For example, TNF-α overproduction has been implicated in septic shock [@B2], autoimmune diseases [@B3] and neurodegenerative diseases [@B4]. Depending on its expression levels, TNF-α may exhibit both beneficial and detrimental effects. However, the mechanism by which a proper level of TNF-α is maintained remains largely unclear.

Production of TNF-α is regulated at both transcriptional and post-transcriptional levels in most systems [@B5], [@B6]. NF-κB, a transcriptional factor known important for cell survival, immunity and inflammation [@B7], plays a predominant role in transcriptional activation of TNF-α in response to several factors, including lipopolysaccharide (LPS) [@B5]. Excessive stimulation of innate immunity, including liver cells by LPS, can lead to TNF-α overproduction and endotoxin shock, a systemic disorder with a high mortality rate in humans and experimental mouse models [@B8].

MicroRNAs (miRNAs) are short RNAs (18-24 nt in length), function as important post-transcriptional regulators of gene expression through modulating the stability and/or translation of the target mRNAs [@B9]-[@B11]. They are involved in numerous physiological and pathological processes, including development, differentiation, metabolism, inflammation, viral infection, and tumorigenesis [@B12]-[@B15]. The miRNAs are involved in the post-transcriptional regulation of TNF-α production. For example, miR-125b targets the 3\'-untranslated region (3\'-UTR) of TNF-α transcripts to suppress TNF-α production [@B16].

Most miRNAs are initially transcribed by RNA polymerase II (poly II) as primary transcripts (pri-miRNAs), which are subsequently cleaved into a hairpin-structured precursor miRNA (pre-miRNA) by Drosha, a nuclear RNase III. Pre-miRNAs are then exported into the cytoplasm and further digested by DICER, another RNase III, to generate mature miRNAs [@B17], [@B18]. In human biliary epithelial cells, NF-κB/p65 activation induced by LPS regulates the expression of a subset of miRNA genes, including pri-miR-125b, pri-miR-21 and pri-miR-130a [@B19]. Moreover, LPS affects the expression of miR-125b, miR-146 and miR-155 in human monocytes [@B16], [@B20]. Therefore, NF-κB may regulate both pri-miRNA expression and miRNA formation.

Although both MITF [@B21] and Tap63 [@B22], two transcriptional factors, have been implicated in regulation of DICER expression, the transcriptional regulation of DICER remains largely unclear. Since NF-κB regulates both TNF-α transcription and miRNA formation, we asked whether transcription of DICER could be regulated by NF-κB to control TNF-α production in septic shock. Here, we reported that NF-κB/p65 controls DICER transcription and that a novel NF-κB/p65-DICER-miRs regulatory circuitry is essential to TNF-α homeostatic production.

Results
=======

NF-κB/p65 regulates DICER expression
------------------------------------

To analysis the transcriptional regulation of *DICER,* we first mapped the regions of *DICER* promoter and found that its core promoter is located at -450 to -180 bp relative to its transcription start site (Figure [1](#F1){ref-type="fig"}A, 1B and [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}A), a region highly conserved among human, mouse and rat. Further the *TRANSFAC* analysis revealed the presence of an NF-κB binding site in this region (Figure [1](#F1){ref-type="fig"}B). Mutagenic analysis confirmed this putative NF-κB regulatory element in *DICER* promoter was functional in both Huh7 cells, a human hepatocarcinoma cell line (Figure [1](#F1){ref-type="fig"}C), and HEK293 cells ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}B). Further, siRNA knockdown and overexpression experiments showed that the p65 subunit rather than the p50 subunit was important for *DICER* promoter activity (Figure [1](#F1){ref-type="fig"}D, [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}C and 1D, and [Supplemental Figure 2](#SM1){ref-type="supplementary-material"}). Additionally, electrophoretic mobility shift assays (EMSA) ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}E and 1F) and chromatin immunoprecipitation (ChIP) assays (Figure [1](#F1){ref-type="fig"}E and [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}G) revealed that *DICER* promoter was physically associated with NF-κB/p65. Consistently, DICER expression induced by LPS (Figure [1](#F1){ref-type="fig"}F and [1](#F1){ref-type="fig"}G), a bacterial endotoxin responsible for septic shock [@B23], and by TNF-α (Figure [1](#F1){ref-type="fig"}H and [1](#F1){ref-type="fig"}I) in mouse embryonic fibroblasts (MEF) deficient for p65 was prevented. Taken together, these results demonstrate that NF-κB/p65 regulates DICER expression.

DICER suppress TNF-α production via NF-κB/p65 activation
--------------------------------------------------------

To explore the functional regulation of NF-κB/p65-DICER axis, we treated Huh7 cells with LPS and followed DICER and TNF-α expression. DICER protein levels in Huh7 cells were increased between 1h and 4h after LPS treatment (Figure [2](#F2){ref-type="fig"}A). Interestingly, its levels in RAW 264.7 cells, a mouse macrophage cell line known abundant for TNF-α production [@B24], were not changed ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}A and 3B). LPS did not increase DICER expression when p65 was down-regulated (Figure [2](#F2){ref-type="fig"}B). In the time course analysis of expression of DICER and TNF-α, we found that DICER mRNA levels were enhanced 1h with the peak at 4h, while TNF-α was at 2h with the peak level at 3h after LPS treatment (Figure [2](#F2){ref-type="fig"}C). This LPS-increased TNF-α mRNA level was greatly enhanced with the peak level at 4h when DICER was down-regulated by DICER RNAi (Figure [2](#F2){ref-type="fig"}D), while NF-κB/p65 activation remained unaffected ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}C and 3D). In contrast, the mRNA levels of IL-6 (Figure [2](#F2){ref-type="fig"}E) and IL-8 (Figure [2](#F2){ref-type="fig"}F), two inflammatory cytokines also regulated by NF-κB [@B25], [@B26], remained unaffected by DICER knockdown in response to LPS. These results suggested that up-regulation of DICER following NF-κB/p65 activation may play an important role in preventing overproduction of TNF-α in Huh7 cells.

NF-κB/DICER axis regulates MiR-125b and miR-130a expression
-----------------------------------------------------------

DICER is an RNase III responsible for production of mature miRNAs. To determine which miRNAs mediate the potential inhibitory effects of DICER on TNF-α production, we analyzed the 3\'-UTR of TNF-α mRNA and found that, miR-125b, miR-19, miR-181, miR-130a and miR-16 target sequences which were reported previously affecting TNF-α expression [@B16], [@B27]-[@B30] ([Supplementary Figure 4](#SM1){ref-type="supplementary-material"}A). Through expressing these miRNAs in HEK293 cells, we found that miR-125b and miR-130a could decrease both TNF-α mRNA levels ([Supplementary Figure 4](#SM1){ref-type="supplementary-material"}B) and the luciferase activities of a luciferase construct with the TNF-α 3\'-UTR (Figure [3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B). Furthermore, through overexpression or RNAi knockdown of either p65 or DICER, we did find that the expression of both miR-125b and miR-130a was regulated by p65 as well as DICER (Figure [3](#F3){ref-type="fig"}C-[3](#F3){ref-type="fig"}F). Knockdown experiments further verified the requirement of DICER for either LPS-induced and p65-dependent expression of both miR-125b and miR-130a (Figure [3](#F3){ref-type="fig"}G-[3](#F3){ref-type="fig"}J). These results suggest that up-regulation of miR-125b and miR-130a by the NF-κB/p65/DICER pathway may be an important mechanism preventing overproduction of TNF-α.

NF-κB/p65-DICER-miRs axis regulates TNF-α production
----------------------------------------------------

We next attempt to study the underlying mechanism of NF-κB/p65-DICER-miRNAs axis in TNF-α production. In response to LPS treatment, the levels of pri-miR-125b and pri-miR-130a were rapidly increased in Huh7 cells (Figures [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). Interestingly, the up-regulation of these pri-miRNAs was further enhanced when DICER was knocked down. In contrast to the changes of the pri-miRNAs, we found that the levels of the mature miR-125b and miR-130a were decreased when DICER was knocked down (Figures [4](#F4){ref-type="fig"}C and [4](#F4){ref-type="fig"}D). These results clearly showed that DICER played an important role in conversion of the pri-miR-125b and pri-miR-130a to their mature forms, and that DICER down-regulation led to an accumulation of the immature forms accompanied by the reduction of their mature forms. To provide further evidence that DICER expression driven by NF-κB indeed affects TNF-α levels, we examined the effects of miR-125b and miR-130a on TNF-α expression. The LPS-induced TNF-α mRNA levels were greatly increased when miR-125b or miR-130a were down-regulated (Figure [4](#F4){ref-type="fig"}E). Consistently, expressing miR-125b and miR-130a reversed the increase in TNF-α mRNA levels caused by DICER down-regulation (Figure [4](#F4){ref-type="fig"}F). These results supported an explanation that increases of miR-130a and miR-125b by DICER activity in the later phase of LPS treatment provides a mechanism in controlling the overproduction of TNF-α. Since TLR-induced gene expression is generally mediated by NF-κB [@B31], we further examined the levels of both primary and mature forms of let-7a, a miRNA known to target IL-6 [@B32]. Neither primary nor mature form of let-7a was affected (Figure [4](#F4){ref-type="fig"}G and [4](#F4){ref-type="fig"}H), suggesting that regulation of IL-6 production was different from that of TNF-α. Taken together, the above results revealed a regulatory mechanism involving NF-κB/p65, DICER, miR-125b and miR-130a that controls TNF-α homeostatic production in response to NF-κB activation in hepatocytes.

NF-κB/p65-DICER-miRNAs axis regulates TNF-α production in LPS induced sepsis shock
----------------------------------------------------------------------------------

Since LPS induced-septic shock is mostly caused by NF-κB-dependent TNF-α production [@B8], we next examined the *in vivo* roles of hepatic DICER in a mouse LPS-induced liver septic shock model. Similar as the results obtained from cultured cells, the expression levels of TNF-α (Figure [5](#F5){ref-type="fig"}A and [5](#F5){ref-type="fig"}B), miR-125b and miR-130a (Figure [5](#F5){ref-type="fig"}C and [5](#F5){ref-type="fig"}D) in mice were all greatly increased in response to LPS treatment. To study the roles of DICER in liver in LPS-induced septic shock, we generated hepatocyte-specific Dicer-deficient mice by breeding Dicer*^flox/flox^* mice (Dicer^F/F^) with mice expressing Cre recombinase under control by either the albumin promoter (Alb-Cre) [@B33] or inducible Mx1 promoter (Mx1-Cre) [@B34], resulting in Dicer^F/F^AlbCre or Dicer^F/F^Mx1Cre mice. Efficient deletion of Dicer in liver was confirmed by quantitative RT-PCR in these mice ([Supplementary Figure 5](#SM1){ref-type="supplementary-material"}A-C). The Dicer^F/F^AlbCre and Dicer^F/F^Mx1Cre mice could survive to adulthood without obvious abnormalities [@B35]. We found that administration of LPS could markedly elevated TNF-α mRNA in the livers and TNF-α protein in sera of Dicer^F/F^AlbCre and Dicer^F/F^Mx1Cre mice, with levels significantly higher than in the control Dicer^F/F^ mice (Figure [5](#F5){ref-type="fig"}E-G). Agreeing well, the mature hepatic miR-125b levels were decreased ([Supplementary Figure 5](#SM1){ref-type="supplementary-material"}D). Notably, although the serum TNF-α levels were not affected, we did observe a significant decrease in miR-125b in the livers of the Dicer^F/+^AlbCre mice after LPS treatment ([Supplementary Figure 5](#SM1){ref-type="supplementary-material"}E and 5F). Collectively, TNF-α production in Dicer mutant mice was much higher and last longer compared with wild type mice after treated with LPS.

We then depleted macrophages by liposome-encapsulated clodronate [@B36], [@B37] and examined LPS-induced TNF-α production. Although depletion of macrophages ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}A) significantly reduced serum TNF-α levels in Dicer^F/F^ and Dicer^F/F^AlbCre mice, but the levels in Dicer^F/F^AlbCre mice still remained much higher than in Dicer^F/F^ mice after LPS injection (Figure [5](#F5){ref-type="fig"}H). In contrast to the observations that the TNF-α production in hepatocytes from Dicer^F/F^AlbCre mice was much greater than that from Dicer^F/F^ mice ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}B), the LPS-induced TNF-α production in the peritoneal macrophages isolated from these mice was not different ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}C).

The serum transaminase activity between these mice was not different ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}D and 6E), suggesting the impact of overproduction of TNF- α was systemic rather than liver-specific. Therefore, DICER upregulation in hepatocytes prevented TNF-α overproduction during LPS treatment, avoiding the systemic effects mediated by TNF-α and other cytokines, which could cause tissue injury, disseminated intravascular coagulation, shock and death [@B34], [@B38].

We then examined the mouse survival after injection with a lethal dose LPS. Eight days after injection, more than 50% of the Dicer^F/F^ mice still remained alive, whereas only 26% Dicer^F/F^AlbCre mice survived the challenge (Figure [6](#F6){ref-type="fig"}A). Further, administration of infliximab, the anti-TNF-α antibody known to block the action of TNF-α [@B39], significantly protected both the Dicer^F/F^AlbCre and Dicer^F/F^ mice from LPS-induced toxicity. Remarkably, while all of the Dicer^F/F^Mx1Cre mice succumbed to LPS 36h after the challenge, 30% of the mice survived when infliximab was given (Figure [6](#F6){ref-type="fig"}B). Moreover, injection of miR-125b mimics could similarly prevent mice from LPS-induced toxicity (Figure [6](#F6){ref-type="fig"}C). These results suggested that the higher mortality rates of the Dicer mutant mice were mainly caused by the systemic effects of hepatic TNF-α overproduction.

Discussion
==========

We have shown here that the NF-κB-dependent transcription of DICER is important for TNF-α homeostasis in hepatocytes. Several lines of evidence support this conclusion. First, activation of NF-κB was sufficient to stimulate DICER promoter activity and induce its expression; NF-κB activation was also necessary for LPS or TNF-α to enhance DICER promoter activity and its expression (Figures [1](#F1){ref-type="fig"}-[3](#F3){ref-type="fig"}). Second, DICER, pri-miR-125b, pri-miR-130a and TNF-α expressions were induced in response to NF-κB activation; but the TNF-α expression was suppressed when the peak expression of DICER and miR-125b occurred (Figure [4](#F4){ref-type="fig"}). Third, after NF-κB activation, DICER processed pri-miR-125b or pri-miR-130a to miR-125b or miR-130a to suppress TNF-α production (Figure [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Finally, inhibition of DICER expression resulted in an enhanced and prolonged production of TNF-α in cultured cells and in mice (Figure [2](#F2){ref-type="fig"}D, 5E, 5F and 5G). These findings led us to propose a model to illustrate how TNF-α production was stringently controlled by NF-κB signaling (Figure [6](#F6){ref-type="fig"}D). The LPS-induced transcription of TNF-α gene is dependent on NF-κB activation. Meanwhile, activation of NF-κB also triggers transcriptional and post-transcriptional mechanisms to suppress TNF-α production or prevent TNF-α overproduction, which involves the upregulation of DICER and pri-miRs and subsequent miRs formation. The outcome of these NF-κB-directed regulatory mechanisms is the balanced production of TNF-α, which is critical for physiological immune and inflammatory responses.

Activation of TLR4 by LPS initiates NF-κB signaling pathway, leading to the production of proinflammatory cytokines, such as TNF-α and IL-6 [@B40], [@B41]. In our study, NF-κB signaling drove a cluster of gene expression, including DICER, miR-125b, miR-130a and TNF-α, in which TNF-α expression was inhibited by DICER/miR-125b/miR-130a. An RNAi-based screening reveals that DICER is required for the rapid decay of TNF-α mRNA in mammalian cells [@B27]. Thus, the NF-κB/DICER pathway forms a novel negative feedback loop in TNF-α production, in which activation of a transcriptional factor (NF-κB) directs the negative feedback achieved by its products (DICER, miR-125b, miR-130a and TNF-α) at post-transcriptional levels. This feedback loop was thus an important and specific mechanism for the fine tune of TNF-α expression since inhibition of DICER expression led to an enhanced production of TNF-α, but not IL-6 or IL-8 (Figures [2](#F2){ref-type="fig"}E and [2](#F2){ref-type="fig"}F).

DICER is the key enzyme of miRNA maturation and ubiquitously expressed. Recent study in epithelial cells uncovered several NF-κB/p65-dependent miRNAs, which expression in the mature form is not increased although the up-regulation of their primary transcripts was found [@B19], [@B42], indicating that post-transcriptional mechanism is also critical in regulation of miRNA expression. Since NF-κB signaling upregulated DICER, pri-miR-125b, pri-miR-130a, miR-125b and miR-130a levels (Figure [4](#F4){ref-type="fig"}A-D), it is possible that NF-κB induced miR-125b and miR-130a expression by activating transcription of pri-miR-125b and pri-miR-130a which were subsequently converted to miR-125b and miR-130a by DICER. Our results also showed that the expression of IL-6, pri-let7 and let-7, a miRNA targeting IL-6, was not regulated by the NF-κB/DICER pathway. These results suggested that post-transcriptional regulation of miRNAs by DICER might require the coordination of transcriptional upregulation of both pri-miRNA transcripts and DICER.

It should be pointed out that NF-κB-dependent transcription of DICER was not observed in the RAW264.7 cell, a mouse macrophage cell line, following LPS stimulation although the production of TNF-α was highly induced ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}A and 3B). That the LPS-induced upregulation of DICER found in Huh7 cells and MEF (non-hematopoietic cells) could not be detected in macrophages suggests that the NF-κB/DICER/miRs pathway was a cell type specific mechanism involved in regulation of TNF-α expression. Since LPS-induced NF-κB activation lasted much longer in these non-hematopoietic cells than in RAW264.7 cells, the long-lasting activation of NF-κB may greatly affect DICER expression. Indeed, the duration of NF-κB activation contributes to the selectivity of the transcriptional response [@B43]. Alternatively, LPS-induced long-lasting NF-κB activation in the non-hematopoietic cells appears to be that TNF-α induced by LPS acts in an autocrine fashion to maintain the long-term NF-κB activation [@B44].

TNF-α is mainly produced by macrophages. But, its expression has been found in a broad variety of cells, including lymphoid cells, endothelial cells, fibroblasts, glia and hepatocytes [@B45]. The production of TNF-α by non-hematopoietic cells have an important role in physiology and pathology of many tissues, including liver [@B46]. Our Kupffer depletion experiments showed a reduction in serum TNF-α level by 50% in mice given LPS, indicating the presence of a non-Kupffer cell source in mice (Figure [5](#F5){ref-type="fig"}H). We also found that TNF-α protein level was increased in LPS-treated isolated hepatocytes ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}B). Our findings consistent with many studies provide evidence that hepatocytes could be considered not only as targets of TNF-α, but also as potentially active participants of the local and systemic cytokine network [@B47], [@B48]. In this context, the transcriptional control of DICER expression in hepatocytes is critical for the homeostatic regulation of TNF-α production in response to NF-κB activation.

Collectively, our results suggested that a novel axis involving NF-κB, DICER, miR-125b and miR-130a that provides important homeostatic regulation in TNF-α production by hepatocytes in addition to Kupffer cells and other macrophages (Figure [6](#F6){ref-type="fig"}D). Down-regulation of DICER affects TNF-α, but not IL-6 or IL-8, in response to NF-κB activation shown here, indicating that temporal and spatial expression of a protein may influence DICER effect on its expression. In term of the importance of TNF-α in septic shock, our findings might present a new hepatocyte-possessing mechanism to limit TNF-α production therapeutically.

Materials and Methods
=====================

Mice
----

Dicer^F/F^(Jax: 006366), Alb-Cre (Jax: 003574) and Mx1-Cre (Jax: 002527) mice were from the Jackson Laboratories. Dicer^F/F^ mice were crossed with Alb-Cre or Mx1-Cre transgenic mice to generate hepatocyte-specific *Dicer*-deficient mice (Dicer^F/F^AlbCre mice) and Dicer^F/F^Mx1Cre mice (efficient deletion in both the liver and hematopoietic cells). Dicer^F/F^AlbCre mice were identified as described previously [@B49]. Deletion of *folxed* alleles in Mx1-Cre mice was performed as described previously[@B34]. Dicer^F/F^ littermates without the *Cre* transgene were served as WT controls. All procedures involving animals were approved by the Institutional Animal Care and Use Committee of the Institute of Neuroscience, Shanghai, China.

Constructs
----------

All plasmid sequences are available upon request. We created human DICER-luciferase reporter constructs by cloning the promoter fragments into the pGL3-Basic luciferase reporter vector (Promega) between KpnI and HindIII. Specific primers for DICER promoter\'s deletion constructs were listed in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. DICER-RNAi plasmids were generated according to the previous report [@B50].

Cell Culture, Transfection and Reagents
---------------------------------------

HEK293 cells, human hepatoma Huh7 cells, mouse embryonic fibroblasts (MEFs) and murine macrophage cell line RAW264.7 were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific) in a 5% CO~2~ atmosphere at 37℃. HeLa cells were cultured in DMEM (Invitrogen) supplemented with 4% FBS (Thermo Fisher Scientific) in a 5% CO~2~ atmosphere at 37℃. Primary hepatocytes were prepared as described[@B51]. Transfections of HEK293, Huh7 cells or HeLa cells with siRNAs (GenePharma, Shanghai; listed in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}) or plasmids were carried out with lipofectamine 2000 (Invitrogen) or FuGene6 (Roche, in HeLa cells) according to the manufacturer\'s protocol. The cells were incubated for 72 h to down-regulate p65 or DICER. The knockdown effect was determined by quantitative RT-PCR and Western blot analysis. Ammonium pyrrolidine dithiocarbamate (APDC, 100 ng/ml), BAY 11-7082 (BAY, 30 μM), BMS-345541 (BMS, 1 μM) and LPS (1 μg/ml) were purchased from Sigma, and TNF-α (10 ng/ml) from R&D. All other reagents were purchased from Shanghai Sangon Biological Engineering Technology & Services Co, Ltd (Shanghai, China) unless otherwise specified.

Luciferase Reporter Assay
-------------------------

For the relative luciferase reporter assay, 1.5×10^5^ cells/well seeded into 12-well plates were transiently cotransfected with 1 µg of the luciferase constructs plus 0.25 µg of galactosidase encoding plasmid DNA in each well. In cotransfection, 1 µg of expression vector for p65 (p65-GFP) or 2 µg of siRNAs against p65 was also added and the total amount of DNA or siRNA added to each well was equalized using the empty vector or nonsense siRNA. We prepared cell extracts 48h after cotransfection. The luciferase activity was analyzed using the luciferase assay system (Promega).

Reverse Transcription and Quantitative PCR
------------------------------------------

Total RNA was isolated using Trizol (Invitrogen) and cDNA was prepared by reverse transcription (MBI Fermentas) followed by real-time PCR analysis (SYBR green; TaKaRa) on a Rotor-Gene Q 2plex HRM analyzer (QIAGEN). Primers used were listed in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}.

Western Blot
------------

Immunoblot analysis was performed by probing target proteins with antibodies listed in [Supplementary Table S2](#SM1){ref-type="supplementary-material"}. The quantitation of protein band density was done using ImageQuant 5.2 software (GE Healthcare).

ChIP Assay
----------

ChIP assays in Huh7 cells were performed using a ChIP Assay Kit (Upstate) following the manufacturer\'s instructions. The cell extracts were subjected to immunoprecipitation using IgG, anti-p65 or anti-p50 antibodies (Santa Cruz). The DNA in the precipitates was extracted and then amplified by qPCR or PCR using primers in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. All the PCR products have been confirmed by sequencing analysis.

Kupffer Cell Depletion
----------------------

Clodronate-containing liposomes were prepared as described[@B52]. Kupffer cells were depleted in mice via intravenous administration of 100 ul liposome-encapsulated clodronate (Sigma) per 25 g body weight 48 h before LPS administration. Control mice were injected with liposome-encapsulated phosphate-buffered saline (PBS). Kupffer cell elimination was confirmed by the measurement of F4/80 (a macrophage maker) mRNA levels using qRT-PCR [@B53].

LPS-induced Endotoxin Shock
---------------------------

At the age of 12 weeks, Dicer^F/F^AlbCre, Dicer^F/F^Mx1Cre and Dicer^F/F^ mice weighing 20-25 g were intraperitoneally injected (i.p.) with NaCl (0.9%) or Infliximab (mAb, 30 μg/g; 3mAb, 90 μg/g) 1 h before application of LPS (10 μg/g). At different time points after injection, blood was taken from the animals and serum was prepared for further analysis. Alanine transaminase (ALT) and aspartate aminotransferase (AST) activities in serum were measured using the ALT and AST Reagent kit (Nanjing Jiancheng Bio-engineering Institute). Animals were continuously monitored for LPS-induced lethality for a period of 8 days after LPS challenge (n=15-19 per treatment group).

Cytokine Level Assays
---------------------

Cytokine concentration in serum was determined by enzyme-linked immunoabsorbent assay (ELISA) at the indicated time points. ELISA assays measuring the levels of TNF-α were carried out with the Mouse TNF-α ELISA kit (R&D systems).

In Vivo Transfection
--------------------

At the age of 12 weeks, Dicer^F/F^AlbCre mice weighing 20-25 g were injected intravenously (i.v.) via lateral tail veins with nonsense or miR-125b mimics (1.5μg/g) 12 h before application of LPS (10 μg/g) using in vivo-jetPEI™-Gal (Polyplus-transfection, New York) according to the manufacturer\'s protocol. Animals were continuously monitored for LPS-induced lethality for a period of 8 days after LPS challenge (n=8-9 per treatment group).

Statistics
----------

All data were presented as mean ± SEM of three independent experiments. Comparisons between groups for statistical significance were performed with Student\'s t test, analysis of variance (ANOVA), or the log-rank test. Results were considered significant difference at \*P\<0.05; \*\*P\<0.01; \*\*\*P\<0.001; ^\#^P\<0.05; ^\#\#^P\<0.01;^\#\#\#^P\<0.001.
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![**NF-κB /p65 regulation of DICER expression.**(A) *DICER* promoter analysis. HEK293 and HeLa cells were transiently transfected with firefly luciferase reporter constructs (pGL3-basic) containing the indicated genomic fragments (Left, schematic diagram) upstream of *DICER* and analyzed for luciferase activities. All luciferase data were normalized to β-galactosidase. Fold changes were shown with respect to pGL3-basic, where the normalized activity was set to value of 1. (B) VISTA schematic diagram showed the phylogenetic conservation between human, mouse and rat in the genomic region upstream of *DICER*. The sequences of predicted κB site (DICER κB probe) and mutated κB (mκB) site. (C) Huh7 cells were transfected with the proximal promoter construct pGL3 (-450/-180) (C) or mκB-pGL3 (-450/-180) (MUT) and subsequently treated with LPS for 4h, TNF-α for 2h, APDC for 8h, BMS or BAY for 1h, and luciferase activity was determined. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001 vs C. (D) Luciferase activities in HEK293 cells transfected with pGL3 (-450/-180) and nonsense siRNA (N.S.), p65-specific siRNA (p65-si1), p65-GFP or empty vector (GFP) each. The activities were relative to those in N.S. or GFP groups. Immunoblots (inset) showing the knockdown or overexpression of p65. \*P\<0.05, \*\*P\<0.01 vs N.S. or GFP. (E) NF-κB/p65 interaction with *DICER* promoter analyzed by ChIP assay. EB staining, qPCR products on a 2% agarose gel; bar graph, statistical analysis of PCR. Data were normalized with the input DNA. \*\*P\<0.01 vs Saline. Wild-type (WT) or p65 KO (p65^-/-^) MEFs were treated with LPS or TNF-α for the indicated times and harvested for qRT-PCR (F and H) or immunoblot (G and I). The mRNA levels of DICER were normalized to those of actin and relative to those in non-stimulated cells. \*P\<0.05, \*\*P\<0.01 vs 0h. ^\#^P\<0.05, ^\#\#^P\<0.01, ^\#\#\#^P\<0.001 vs WT. All quantitative data, unless stated, were means ± SEM of three independent experiments in triplicates and tubulin served as a loading control in all immunoblots.](ijbsv11p1257g001){#F1}

![**NF-κB /p65-induced DICER expression suppressed TNF-α production.**(A) Huh7 cells treated with LPS for the indicated times were harvested for immunoblot. (B) Huh7 cells transfected with Scr or p65-si1 for 72h and treated with LPS for 4h were lysated for immunoblot. (C) The mRNA levels of DICER and TNF-α in Huh7 cells stimulated by LPS and normalized to those of actin. \*P\<0.05, \*\*P\<0.01, ^\*\*\*^P\<0.001 vs 0h. The mRNA levels of TNF-α (D), IL-6 (E) and IL-8 (F) in Huh7 cells transfected with N.S. or DICER RNAi plasmids (DICER RNAi) for 72h and treated with LPS and normalized to those of actin. ^\#^P\<0.05, ^\#\#^P\<0.01 vs N.S..](ijbsv11p1257g002){#F2}

![**MiR-125b and miR-130a expression was regulated by NF-κB/DICER pathway.**(A) Top: Sequence alignment of miR-125b and its target sites in 3′-UTR of TNF-α in human. Gray Characters: the mutant seed sequence. Lower: A luciferase reporter construct containing a \~240bp fragment of the TNF-α 3′-UTR with the miR-125b binding site was made. The luciferase activity in HEK293 cells transfected with Wild type (WT) or mutant reporter plasmids (Mutant) and miR-125b (miR-125b) or empty plasmid (Ctrl) for 48h was determined. \*\*P\<0.01 vs Ctrl. (B) Top: Sequence alignment of miR-130a and its target sites in 3′-UTR of TNF-α in human. Gray Characters: the mutant seed sequence. Lower: A luciferase reporter construct containing a \~240bp fragment of the TNF-α 3′-UTR with the miR-130a binding site was made. The luciferase activity in HEK293 cells transfected with Wild type (WT) or mutant reporter plasmids (Mutant) and miR-130a (miR-130a) or empty plasmid (Ctrl) for 48h was determined. \*\*P\<0.01vs Ctrl. The expression of miR-125b or miR-130a in Huh7 cells transfected with GFP, DICER or p65-GFP (C and E) for 48h; N.S., DICER RNAi or p65-si1 (D and F) for 72h was determined by qRT-PCR. \*P\<0.05, \*\*P\<0.01 vs GFP or N.S. The levels of miR-125b (G) or miR-130a (I) in Huh7 cells cotransfected with N.S. and GFP (N.C.) or DICER RNAi and p65-GFP for 72h were determined. \*P\<0.05, \*\*P\<0.01 vs N.C. MiR-125b (H) or miR-130a (J) levels in Huh7 cells transfected with N.S. or DICER RNAi for 72h and treated with LPS for 4h were determined., \*\*P\<0.01 vs N.S. All quantitative data were means ± SEM of three independent experiments in triplicates. The levels of miR-125b and miR-130a were normalized to those of actin mRNA.](ijbsv11p1257g003){#F3}

![**MiRs were upregulated to inhibit TNF-α production induced by p65/DICER signaling.**Pri-miR-125b (A), pri-miR-130a (B), miR-125b (C) and miR-130a (D) levels in Huh7 cells transfected with N.S. or DICER RNAi for 72h and stimulated with LPS were determined and normalized to actin mRNA levels. \*P\<0.05, \*\*P\<0.01vs 0h. (E) TNF-α mRNA levels in Huh7 cells transfected with negative control (NC), miR-125b or miR-130a AS for 72h and treated with LPS were determined and normalized to actin mRNA levels. \*P\<0.05, \*\*P\<0.01 vs 0h. (F) TNF-α mRNA levels in Huh7 cells transfected with DICER RNAi in addition to miNC, miR-125b or miR130a for 72h and stimulated with LPS were determined and normalized to actin mRNA levels. \*P\<0.05 vs 0h. Pri-let-7a-1, pri-let-7a-2 (G) and mature let-7a (H) levels in Huh7 cells stimulated with LPS were determined and normalized to actin mRNA levels.](ijbsv11p1257g004){#F4}

![**Dicer expression was important for hepatic TNF-α expression in mice.**(A) Dicer mRNA levels in the purified hepatocytes of Dicer^F/F^ mice treated with saline (Ctrl) or LPS for 1h. Each dot represented the measurement of an animal (n=5). \*\*P\<0.01 vs Ctrl. (B) Immunoblots of total proteins isolated from the purified hepatocytes of Dicer^F/F^ mice treated with LPS for 4h. MiR-125b (C) and miR-130a (D) levels in the purified hepatocytes of Dicer^F/F^ mice treated with saline (Ctrl) or LPS for 1h. Each dot represented measurement of an animal (n=5). \*\*P\<0.01 vs Ctrl. The mRNA levels of hepatic TNF-α in Dicer^F/F^AlbCre (E) or Dicer^F/F^Mx1Cre (F) mice treated with LPS were measured, normalized to those of hepatic actin (n=5). \*\*P\<0.01 vs Dicer^F/F^. (G) Serum TNF-α levels of mice after LPS treatment were measured by ELISA (n=5). \*P\<0.05, \*\*P\<0.01 vs Dicer^F/F^. (H) Serum TNF-α levels in liposome-treated Dicer^F/F^AlbCre or Dicer^F/F^ mice treated with LPS for 1h (n=6). \*\*P\<0.01 vs PBS, \*P\<0.05 vs Dicer^F/F^ or PBS (Dicer^F/F^AlbCre).](ijbsv11p1257g005){#F5}

![**Knock down of DICER greatly sensitized mice to septic shock.**Survival of Dicer^F/F^AlbCre (A) or Dicer^F/F^Mx1Cre (B) mice injected intraperitoneally with saline or Infliximab (30μg/g, mAb or 90μg/g, 3mAb) 1 h before application of LPS was monitored over a period of 8 days (n=15-19). \*P\<0.05 vs Dicer^F/F^. (C) Survival of Dicer^F/F^AlbCre mice injected intravenously (i.v.) via lateral tail veins with nonsense (N.S.) or miR-125b mimics (1.5μg/g)12h before application of LPS was monitored over a period of 8 days (n=8-9). \*P\<0.05 vs N.S.. (D)A model depicting NF-κB-DICER-miRs regulatory circuitry in hepatic TNF-α expression. NF-κB activation induced TNF-α expression and also directed the expression of DICER and miRs to prevent overproduction of TNF-α.](ijbsv11p1257g006){#F6}
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